Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could be ...

SEOUL, South Korea, Dec. 26, 2025 /PRNewswire/ -- ABL Bio (CEO Sang Hoon Lee), a company specializing in bispecific antibodies, announced that ABL Bio will receive a USD 40 million upfront payment for ...

Behringer is no stranger to remaking classic synthesizers and selling them at much cheaper price points. However, this latest release may just take the budget-friendly cake. The company just ...

Eli Lilly's $2.6 billion agreement with ABL Bio focuses on developing therapeutics using the Grabody Platform for bispecific antibodies. ABL Bio will receive an upfront payment and potential milestone ...

ABL Bio Inc. inked a license and research agreement with Eli Lilly and Co. worth up to $2.6 billion to develop multiple therapeutics using the Grabody-B platform. Under the terms announced Nov. 12, ...

Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into the clinic. ABL, a Korean biotech that is partnered with companies ...

ABL Bio announced on the 1st that it confirmed the safety and tolerability of the treatment candidate ABL301 (SAR446159) for degenerative brain diseases such as Parkinson's disease in a U.S. Phase 1 ...

Former small-satellite launch company ABL Space Systems has capped a transformation to focus on missile defense by changing its name, the CEO of newly rebranded Long Wall announced Feb. 19. "As our ...

ABL Bio, which is developing new drugs based on a dual antibody platform, noted that it is in discussions with a global top-tier pharmaceutical company regarding technology transfer. On the 23rd, ABL ...

Kate Starbird and Jamila Wideman sat in a conference room after finishing their senior seasons at Stanford in April 1997 with something that hadn't been previously available to women's college ...

Robbie has been an avid gamer for well over 20 years. During that time, he's watched countless franchises rise and fall. He's a big RPG fan but dabbles in a little bit of everything. Writing about ...

ORLANDO, Fla., Nov. 27, 2024 (GLOBE NEWSWIRE) -- ABL Technologies, LLC (“ABL Tech”), a groundbreaking technology platform that revolutionizes how organizations manage and reconcile mortality data, and ...